LU76998A1 - - Google Patents

Info

Publication number
LU76998A1
LU76998A1 LU76998A LU76998A LU76998A1 LU 76998 A1 LU76998 A1 LU 76998A1 LU 76998 A LU76998 A LU 76998A LU 76998 A LU76998 A LU 76998A LU 76998 A1 LU76998 A1 LU 76998A1
Authority
LU
Luxembourg
Application number
LU76998A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/772,851 external-priority patent/US4146614A/en
Application filed filed Critical
Publication of LU76998A1 publication Critical patent/LU76998A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU76998A 1976-03-23 1977-03-23 LU76998A1 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66952676A 1976-03-23 1976-03-23
US05/772,851 US4146614A (en) 1976-03-23 1977-02-28 Threonyl-valyline leucine containing peptides and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
LU76998A1 true LU76998A1 (cg-RX-API-DMAC10.html) 1977-10-03

Family

ID=27100128

Family Applications (1)

Application Number Title Priority Date Filing Date
LU76998A LU76998A1 (cg-RX-API-DMAC10.html) 1976-03-23 1977-03-23

Country Status (13)

Country Link
JP (1) JPS52142015A (cg-RX-API-DMAC10.html)
AU (1) AU510679B2 (cg-RX-API-DMAC10.html)
CA (1) CA1103239A (cg-RX-API-DMAC10.html)
DE (1) DE2712781A1 (cg-RX-API-DMAC10.html)
DK (1) DK125177A (cg-RX-API-DMAC10.html)
FR (1) FR2351954A1 (cg-RX-API-DMAC10.html)
GB (1) GB1561247A (cg-RX-API-DMAC10.html)
GR (1) GR63642B (cg-RX-API-DMAC10.html)
LU (1) LU76998A1 (cg-RX-API-DMAC10.html)
NL (1) NL7703124A (cg-RX-API-DMAC10.html)
NO (1) NO771031L (cg-RX-API-DMAC10.html)
NZ (1) NZ183627A (cg-RX-API-DMAC10.html)
SE (1) SE7702925L (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ214543A (en) * 1984-12-14 1990-03-27 Australian Commercial Research Amino acid and peptide derivatives that inhibit human leucocytic elastase enzyme (hle)
JPH03236315A (ja) * 1989-12-05 1991-10-22 Nippon Oil & Fats Co Ltd 抗精神病薬

Also Published As

Publication number Publication date
AU2317477A (en) 1978-09-14
JPS52142015A (en) 1977-11-26
SE7702925L (sv) 1977-09-24
AU510679B2 (en) 1980-07-10
DE2712781A1 (de) 1977-10-06
GR63642B (en) 1979-11-27
FR2351954A1 (fr) 1977-12-16
FR2351954B1 (cg-RX-API-DMAC10.html) 1980-03-28
CA1103239A (en) 1981-06-16
NL7703124A (nl) 1977-09-27
NO771031L (no) 1977-09-26
GB1561247A (en) 1980-02-13
NZ183627A (en) 1980-02-21
DK125177A (da) 1977-09-24

Similar Documents

Publication Publication Date Title
IN146455B (cg-RX-API-DMAC10.html)
FR2363926B3 (cg-RX-API-DMAC10.html)
FR2351954B1 (cg-RX-API-DMAC10.html)
JPS5329132U (cg-RX-API-DMAC10.html)
JPS5312216U (cg-RX-API-DMAC10.html)
JPS5620948B2 (cg-RX-API-DMAC10.html)
JPS52123049U (cg-RX-API-DMAC10.html)
CS177446B1 (cg-RX-API-DMAC10.html)
JPS5358645U (cg-RX-API-DMAC10.html)
JPS5346057U (cg-RX-API-DMAC10.html)
JPS5391158U (cg-RX-API-DMAC10.html)
JPS5297954U (cg-RX-API-DMAC10.html)
JPS52117993U (cg-RX-API-DMAC10.html)
JPS5299544U (cg-RX-API-DMAC10.html)
CH607266A5 (cg-RX-API-DMAC10.html)
CH608701A5 (cg-RX-API-DMAC10.html)
CH606592A5 (cg-RX-API-DMAC10.html)
DD124013A1 (cg-RX-API-DMAC10.html)
DD124818A1 (cg-RX-API-DMAC10.html)
DD124158A1 (cg-RX-API-DMAC10.html)
BG23126A1 (cg-RX-API-DMAC10.html)
DD124413A1 (cg-RX-API-DMAC10.html)
CH611502A5 (cg-RX-API-DMAC10.html)
DD124092A1 (cg-RX-API-DMAC10.html)
CH599128A5 (cg-RX-API-DMAC10.html)